Jeff Smith
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Molecular Biology top 10%
- CRISPR and Genetic Engineering
- Mitochondrial Function and Pathology
- RNA Interference and Gene Delivery
- Plant tissue culture and regeneration
Papers in
-
- CRISPR and Genetic Engineering 9
- Mitochondrial Function and Pathology 2
- RNA Interference and Gene Delivery 1
- Oncology 4
- CAR-T cell therapy research 4
- Co-authors
- Derek Jantz (12 shared papers)Michael G. Nicholson (5 shared papers)Janel Lape (5 shared papers)L. Alexander Lyznik (1 shared paper)S. Carl Falco (1 shared paper)Dennis L. Bidney (1 shared paper)Huirong Gao (1 shared paper)Spencer Jones (1 shared paper)
- Journals
- Molecular Therapy (4 papers)Molecular Plant (1 paper)Blood (1 paper)Nature Communications (1 paper)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United StatesUnited KingdomIsrael
In The Last Decade
Jeff Smith
19 papers receiving 886 citations
Peers
Comparison fields: 5 of 48
- Oncology 260
- Molecular Biology 513
- Biotechnology 21
- Genetics 86
- Plant Science 80
Countries citing papers authored by Jeff Smith
This map shows the geographic impact of Jeff Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff Smith more than expected).
Fields of papers citing papers by Jeff Smith
This network shows the impact of papers produced by Jeff Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff Smith. The network helps show where Jeff Smith may publish in the future.
Co-authors
The 25 scholars most cited alongside Jeff Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 241 | |
| 2 | 2009 | 218 | |
| 3 | 2018 | 101 | |
| 4 | 2021 | 77 | |
| 5 | 2012 | 50 | |
| 6 | 2015 | 43 | |
| 7 | 2022 | 40 | |
| 8 | 2021 | 35 | |
| 9 | 2023 | 33 | |
| 10 | 2022 | 28 | |
| 11 | 2023 | 27 | |
| 12 | 2022 | 16 | |
| 13 | 2022 | 5 | |
| 14 | 2023 | 5 | |
| 15 | 2016 | 4 | |
| 16 | Rho 1-2 meganuclease, an allele-specific gene-editing therapy, rejuvenates rod photoreceptor structure and function in a pig model of autosomal dominant Retinitis Pigmentosa (adRP). | 2021 | 2 |
| 17 | 2025 | 2 | |
| 18 | 2016 | 1 | |
| 19 | 2026 | 1 |
About Jeff Smith
Jeff Smith is a scholar working on Molecular Biology, Oncology, Biotechnology, Neurology and Genetics, having authored 19 papers that have together received 929 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (9 papers), CAR-T cell therapy research (4 papers), Mitochondrial Function and Pathology (2 papers), Virus-based gene therapy research (2 papers), Transgenic Plants and Applications (2 papers), CNS Lymphoma Diagnosis and Treatment (2 papers), RNA Interference and Gene Delivery (1 paper) and Genetically Modified Organisms Research (1 paper). The work is most often cited by research in Oncology (260 citations), Molecular Biology (513 citations), Biotechnology (21 citations), Genetics (86 citations) and Plant Science (80 citations). Jeff Smith has collaborated with scholars based in United States, United Kingdom and Israel. Frequent co-authors include Derek Jantz, Michael G. Nicholson, Janel Lape, L. Alexander Lyznik, S. Carl Falco, Dennis L. Bidney, Huirong Gao, Spencer Jones, Meizhu Yang and Vesna Djukanovic. Their work appears in journals such as Molecular Therapy, Molecular Plant, Blood, Nature Communications and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.